DDInter456 DDInter1625
Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the liver to form the active aldophosphamide. It has been used in the treatment of lymphoma and leukemia. Its side effect, alopecia, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.
Rubella virus vaccine is a live attenuated virus vaccine for active immunization against rubella (German measles) that is subcutaneously administered. It is prepared from RA 27/3 strain of live attenuated rubella virus. Rubella is a common childhood disease, caused by rubella virus (togavirus).
Cyclophosphamide {u} (Compound) resembles {v} (Compound) Mechlorethamine
Cyclophosphamide {u} (Compound) binds {v} (Gene) CYP3A4
Cyclophosphamide {u} (Compound) downregulates {v} (Gene) ENOPH1
Cyclophosphamide {u} (Compound) causes {v} (Side Effect) Impaired healing
Cyclophosphamide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Modafinil
Cyclophosphamide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Peginterferon alfa-2a
Cyclophosphamide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Mitomycin
Cyclophosphamide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Lorlatinib
Cyclophosphamide {u} may lead to a major life threatening interaction when taken with {v} Golimumab
Cyclophosphamide {u} may lead to a major life threatening interaction when taken with {v} Cladribine
Cyclophosphamide (Compound) resembles Mechlorethamine (Compound)
Cyclophosphamide (Compound) binds CYP3A4 (Gene)
Cyclophosphamide (Compound) downregulates ENOPH1 (Gene)
Cyclophosphamide (Compound) causes Impaired healing (Side Effect)
Cyclophosphamide may cause a minor interaction that can limit clinical effects when taken with Modafinil
Cyclophosphamide may cause a minor interaction that can limit clinical effects when taken with Peginterferon alfa-2a
Cyclophosphamide may cause a moderate interaction that could exacerbate diseases when taken with Mitomycin
Cyclophosphamide may cause a moderate interaction that could exacerbate diseases when taken with Lorlatinib
Cyclophosphamide may lead to a major life threatening interaction when taken with Golimumab
Cyclophosphamide may lead to a major life threatening interaction when taken with Cladribine